Figure 1.
(A) Overall HCC recurrence after DAA treatment. (B) Lowest recurrence rates removed to decrease heterogeneity
CI, confidence interval; HCC, hepatocellular carcinoma; DAA, direct-acting antiviral agents
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.